Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Sep-Oct;17(5):571-577.
doi: 10.21873/cgp.20213.

The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk

Affiliations
Observational Study

The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk

Li-Hsiou Chen et al. Cancer Genomics Proteomics. 2020 Sep-Oct.

Abstract

Background: The study aims to evaluate the contribution of excision repair cross-complementing group 1 (ERCC1), which plays an important role in genome integrity maintenance, to lung cancer risk.

Materials and methods: ERCC1 rs11615 and rs3212986 genotypes were identified by polymerase chain reaction-restriction fragment length polymorphism analysis and their association with lung cancer risk was examined among 358 lung cancer patients and 716 controls.

Results: The proportions of CC, CT and TT for the rs11615 genotype were 43.6%, 41.6% and 14.8% in the case group and 50.0%, 41.1% and 8.9% in the control group, respectively (p for trend=0.0082). Allelic analysis showed that ERCC1 rs11615 T-allele carriers have a 1.32-fold higher risk of lung cancer than wild-type C-allele carriers [95%confidence interval (CI)=1.09-1.60, p=0.0039]. In addition, a significant interaction between the rs11615 genotype and smoking status was observed.

Conclusion: The T allele of ERCC1 rs11615 jointly with smoking habits may contribute to a higher lung cancer risk in Taiwan.

Keywords: ERCC1; Taiwan; genotype; lung cancer; polymorphism; smoking.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest regarding this study.

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48(3):889–902. doi: 10.1183/13993003.00359-2016. - DOI - PubMed
    1. Rivera GA, Wakelee H. Lung Cancer in never smokers. Adv Exp Med Biol. 2016;893:43–57. doi: 10.1007/978-3-319-24223-1_3. - DOI - PubMed
    1. Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence: Cancer Registration Annual Report. Available at: https://www.hpa.gov.tw/Pages/List.aspx?nodeid=269 [Last Accessed on May 18th, 2020]
    1. Wu MF, Wang YC, Shen TC, Chang WS, Li HT, Liao CH, Gong CL, Wang ZH, Tsai CW, Hsia TC, Bau DT. Significant association of interleukin-16 genetic variations to Taiwanese lung cancer. In Vivo. 2020;34:1117–1123. doi: 10.21873/invivo.11883. - DOI - PMC - PubMed

Publication types

MeSH terms